SinoMab BioScience Limited (stock code: 3681.HK) is a Hong Kong based clinical-phase biopharmaceutical company focus on the development of novel and high-value recombinant therapeutic proteins for treating various life-threatening and debilitating diseases in human.
| Website | http://www.sinomab.com |
| Revenue | $13.9 million |
| Employees | 38 (23 on RocketReach) |
| Founded | 2001 |
| Phone | +1 703-993-8898 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing |
| Keywords | Bioprocessing, Biopharmaceutical, Novel Therapeutics, Therapeutic Proteins, Recombinant Proteins, Clinical Stage, Drug Development, Biotechnology, Pharmaceutical Research, Immunology, Oncology, Biologics, Monoclonal Antibodies, Protein Engineering, Drug Discovery, Life Sciences, Biosimilars, Clinical Trials, Pharmaceutical Manufacturing, Healthcare |
| Competitors | WuXi AppTec, 百济神州医药信息咨询(上海)有限公司, Zai Lab, Innovent Biologics, I-Mab Biopharma, Sinopharm, CanSino Biologics Inc.康希诺生物, Ascletis Pharma Inc., 微芯生物, Alibaba Health Information Technology +30 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular SinoMab BioScience Ltd. employee's phone or email?
SinoMab BioScience Ltd. Questions
The SinoMab BioScience Ltd. annual revenue was $13.9 million in 2026.
Nathan Lin is the VP, Business Development and Strategy of SinoMab BioScience Ltd..
23 people are employed at SinoMab BioScience Ltd..
The NAICS codes for SinoMab BioScience Ltd. are [3254, 32541, 32, 325].
The SIC codes for SinoMab BioScience Ltd. are [28, 283].
Top SinoMab BioScience Ltd. Employees
-
15
-
Lucy Lu
人力资源经理 at SinoMab BioScience Ltd.
Suzhou, CN1 -
Chan Sally
Recruiter at SinoMab BioScience Ltd.
New Territories, Hong Kong1
Related Companies
